About Laropiprant,Nicotinic Acid (Niacin)
            
            Class: | Combination of a prostaglandin receptor antagonist (Laropiprant) and a lipid-altering agent (Nicotinic Acid)  
Use: | Used for the treatment of dyslipidemia, specifically to lower LDL cholesterol and triglycerides while raising HDL cholesterol in patients at risk for cardiovascular disease  
Adult dose: | 20 mg of Laropiprant and 1 g of Nicotinic Acid (Niacin) once daily, taken with food to minimize flushing  
Pediatric dose: | Safety and efficacy not established in pediatric patients; 
         
        
            
                
                
                    
                        Drug Class
                    
                    Combination of a prostaglandin receptor antagonist (Laropiprant) and a lipid-altering agent (Nicotinic Acid)
                 
                
                
                    
                        Uses & Indications
                    
                    Used for the treatment of dyslipidemia, specifically to lower LDL cholesterol and triglycerides while raising HDL cholesterol in patients at risk for cardiovascular disease
                 
                
                
                    
                        Storage Requirements
                    
                    Store at room temperature (20-25°C or 68-77°F) in a tightly closed container, protected from moisture and light
                 
                
                
                    
                        Manufacturer & Packaging
                    
                    
                        Manufacturer: Merck Sharp & Dohme Limited, UNITED KINGDOM
                    
                    
                    Package Size
                    56's (7's Blister x 8)
                    
                    
                    Price & Supplier
                    
                        Price in UAE: AED 198.50
                    
                    
                 
             
            
                
                
                    
                        Dosage Information
                    
                    
                        Adult Dose
                    
                    
                        20 mg of Laropiprant and 1 g of Nicotinic Acid (Niacin) once daily, taken with food to minimize flushing
                    
                    
                        Pediatric Dose
                    
                    
                        Safety and efficacy not established in pediatric patients; not recommended for use in children
                    
                 
                
                
                    
                        Side Effects
                    
                    Flushing, pruritus, gastrointestinal disturbances (nausea, vomiting, diarrhea), headache, dizziness, and potential liver enzyme elevation
                 
             
         
        
        
            
                Contraindications & Precautions
            
            Hypersensitivity to any component of the formulation, active liver disease, severe gout, and persistent elevated transaminases
         
        
        
            
                Important Warnings
            
            Risk of hepatotoxicity, especially with high doses of Niacin; monitor liver function tests; may cause serious skin reactions; caution in patients with diabetes, as it may affect glucose control; avoid use with other medications that can cause liver damage
         
        
        
        
        
        
        
        
        
            
                Medical Disclaimer
            
            
                This information is for educational purposes only and should not replace professional medical advice. 
                Always consult with a licensed healthcare provider or pharmacist in the UAE before taking any medication. 
                The information presented here is specific to medicines available in UAE pharmacies and is regularly updated 
                to ensure accuracy for patients and healthcare professionals in the United Arab Emirates.